Cannabidiol in Youth Alcohol Use Disorder

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2024-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to test cannabidiol (CBD) as a potentially effective candidate medication for youth alcohol use disorder (AUD). To accomplish this goal, this study will use a randomized, double-blind, within-subjects crossover design. In counterbalanced order, 50 youth (ages 16-22) will receive 600 mg of CBD or placebo three hours before a neuroimaging and behavioral assessment paradigm. The total amount of time the participant will be in the study is approximately one month.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cannabidiol for Alcohol Use Disorder

NCT03904849

Alcohol Use Disorder

WITHDRAWN PHASE1/PHASE2

CBD for the Treatment of Alcohol Use Disorder

NCT04873453

Alcohol Use Disorder

COMPLETED PHASE2

Effects of Cannabidiol in Alcohol Use Disorder

NCT03252756

Alcohol Use Disorder

COMPLETED PHASE1/PHASE2

Alcohol Use Disorder and Cannabidiol

NCT05613608

Alcohol Use Disorder

RECRUITING PHASE2/PHASE3

Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder

NCT06512389

Alcohol Use Disorder

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cannabidiol, Then Placebo

Group Type EXPERIMENTAL

Cannabidiol

Intervention Type DRUG

In counterbalanced order, 50 youth (ages 16-22) will receive 600mg of cannabidiol or placebo three hours before a neuroimaging and behavioral assessment paradigm, separated by an approximate 18-day washout period.

Placebo, Then Cannabidiol

Group Type EXPERIMENTAL

Cannabidiol

Intervention Type DRUG

In counterbalanced order, 50 youth (ages 16-22) will receive 600mg of cannabidiol or placebo three hours before a neuroimaging and behavioral assessment paradigm, separated by an approximate 18-day washout period.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cannabidiol

In counterbalanced order, 50 youth (ages 16-22) will receive 600mg of cannabidiol or placebo three hours before a neuroimaging and behavioral assessment paradigm, separated by an approximate 18-day washout period.

Intervention Type DRUG